Generating Evidence For A Strong Foundation: Using Population Health Data For Translational Child Health, Healthcare And Policy
Funder
National Health and Medical Research Council
Funding Amount
$1,500,000.00
Summary
Professor Natasha Nassar’s research program uses advanced research methods to address new challenges in child population health. She will investigate the role and impact of early life factors, paediatric healthcare practices and long-term morbidity and survivorship on child health and development. Identification of at-risk children and involvement of clinicians and policy-makers in research will ensure improved child population health and development and healthy start to life for all children.
Early Detection And Treatment Of Rheumatic Heart Disease In High Risk Communities Using Community-led Approaches For Active Case Finding, Education And Engagement In Care
Funder
National Health and Medical Research Council
Funding Amount
$358,752.00
Summary
Rheumatic heart disease (RHD) affects many Aboriginal and Torres Strait Islander people. Early detection using an ultrasound of the heart (called an “echo”) can help children access treatment. Echo screening in remote communities needs active community participation and leadership in order to succeed. I will study new approaches to community-led echo screening to see if they are accurate enough, evaluate the impact of community involvement and describe outcomes for those diagnosed with RHD.
Innovation For Health Service Provision And Clinical Management Of Cardiovascular Disease Prevention
Funder
National Health and Medical Research Council
Funding Amount
$1,338,220.00
Summary
Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality globally and had a steep rise in burden in low- and middle income countries. A greater focus on a preventative model of care is needed. Frugal innovation is the concept of creating small, low-cost solutions to big problems. My goal is to discover and robustly evaluate in real-world setting low-cost interventions that can be scaled and implemented to reduce the burden of CVD globally.
LIFESPAN-CHD – Leading Innovation By Finding And Eliminating Gaps In Research, SPecialist Care ANd Mental Health Services For People With CHD.
Funder
National Health and Medical Research Council
Funding Amount
$462,644.00
Summary
Keeping patients and families engaged in congenital heart disease (CHD) care is vital for improving health outcomes for Australians living with CHD. This collaboration will position Australia at the forefront of CHD care and research by delivering healthcare innovations including a national CHD health services dataset, a digital health tool that maximises engagement in CHD care and new models of care co-designed with CHD patients and families to meet their cardiac and mental health needs.
Driving Change To Improve Aboriginal And Torres Strait Islander Kidney Health
Funder
National Health and Medical Research Council
Funding Amount
$1,050,000.00
Summary
The burden of kidney disease affecting Aboriginal and Torres Strait Islander communities is devastating. Community members prioritise prevention of kidney disease, early detection and treatment to stop progression to dialysis. In remote areas, people requiring dialysis have to move away from their family and supports. This work will focus on innovative ways to address this disparity to improve care, treatment and services for Indigenous people living with kidney disease.
Transforming Treatment Options And Delivery Of Care For Osteoarthritis
Funder
National Health and Medical Research Council
Funding Amount
$2,510,793.00
Summary
Osteoarthritis is highly prevalent and a leading cause of disability. Despite this burden, current management is frequently inappropriate and associated with enormous financial costs. This program of research leverages established resources and existing funding to investigate the key challenges for OA in the next decade, including 1) Further enhance the methods for disease modification trials and deploy novel trials, and 2) Optimise the delivery of care for those with extant disease.
Improving The Neurological And Mental Health Of Vulnerable Children: Through Implementation And Health Services Research To Close Treatment Gaps
Funder
National Health and Medical Research Council
Funding Amount
$1,562,250.00
Summary
This Emerging Leader fellowship will support research to improve child neurodevelopmental and mental health. The program of research will answer several of the crucial research questions expressed in the Oct 2019 Productivity Commission Mental Health Report, the 2018 National FASD Strategy, the 2018 Senate Mental Health Inquiry Report, the 2018 Lancet Commission for Mental Health, the 2018 MRFF Strategic Priorities, and 2018 WHO National Strategy for Australian Telehealth Discussion paper.
The Impact Of Breast Density Notification In Australia
Funder
National Health and Medical Research Council
Funding Amount
$645,205.00
Summary
Breast density is an independent risk factor for breast cancer and it increases the risk of having a cancer missed during screening. Notifying women about their breast density has been endorsed as a way to combat this risk. However, the evidence to support breast density notification and recommendations for supplemental screening in the general population of women is far from clear. This research will provide critical new evidence to ensure that Australian women receive evidence-based care.
This Investigator Grant will transform the way follow-up care is delivered to thousands of cancer survivors who have completed treatment by using a shared-care approach between cancer specialists and GPs. This Grant will shift the paradigm of follow-up survivorship care from predominantly acute to primary care by maximising the involvement of GPs and reduce fragmentation of care. This approach is key to enhancing patient-centred care and system sustainability.
Quantifying And Reducing The Burden Of New And Emerging Psychoactive Substances In Australia
Funder
National Health and Medical Research Council
Funding Amount
$645,205.00
Summary
The public health threat posed by emerging drugs of concern (e.g., new psychoactive substances (NPS) and crystalline methamphetamine) requires timely and effective public health interventions. This research program will strengthen estimates of the global NPS health burden, enhance the surveillance of unwitting drug consumption, and develop and evaluate novel harm reduction responses. Findings will inform policy and health service delivery, both globally and within Australia.